Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2026-01-08 @ 5:31 AM
Study NCT ID:
NCT06547203
Status:
RECRUITING
Last Update Posted:
2024-08-09
First Post:
2024-07-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-18
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-07-18
First Submit QC Date:
None
Study First Post Date:
2024-08-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-06
Last Update Post Date:
2024-08-09
Last Update Post Date Type:
ACTUAL